Animals and tumor cell implantation

NE Nada H. Eisa
VC Vincent M. Crowley
AE Asif Elahi
VK Vamsi Krishna Kommalapati
MS Michael A. Serwetnyk
TL Taoufik Llbiyi
SL Sumin Lu
KK Kashish Kainth
YJ Yasmeen Jilani
DM Daniela Marasco
AA Abdeljabar El Andaloussi
SL Sukyeong Lee
FT Francis T.F. Tsai
PR Paulo C. Rodriguez
DM David Munn
EC Esteban Celis
HK Hasan Korkaya
AD Abdessamad Debbab
BB Brian Blagg
AC Ahmed Chadli
ask Ask a question
Favorite

A) C57BL/6 (B6) and BALB/cJ mice implantation: 5 × 104 E0771-luc or 4T1 cells were implanted in the mammary fat pad of seven-to eight-week-old C57BL/6 (B6) or BALB/c female mice, respectively. Ten days following implantation, mice were intraperitoneally injected for the time course of the experiment as follows: EnnA (10 mg/kg) or 17-AAG (50 mg/kg), or DMSO (control). Animal body weight and tumor volume were measured and recorded. At the end of the experiment, mice were necropsied, and tumor tissues and spleens were carefully dissected. Collected tissues were further processed for histopathological, flow cytometric, Western blotting, and RTqPCR analyses. B) Nude mouse implantation: 5 × 104 E0771-luc cells were implanted in the mammary fat pad of seven-to eight-week-old female nude mice. Ten days following implantation, mice were intraperitoneally injected for the time course of the experiment with EnnA (10 mg/kg) or DMSO (control). Animal body weight and tumor volume were measured and recorded. All mouse procedures were conducted in accordance with the University Committee on the Use and Care of Animals at Augusta University.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A